Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (10): 1008-1010.DOI: 10.3969/j.issn.1673-8640.2015.10.011
Previous Articles Next Articles
Received:2015-02-15
Online:2015-10-30
Published:2015-11-04
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.10.011
| 组别 | 例数 | PT(s) | TT(s) | APTT(s) | INR | Fib(g/L) |
|---|---|---|---|---|---|---|
| 治疗前 | 36 | 23.27±0.92 | 24.68±5.04 | 61.50±9.24 | 2.32±0.37 | 1.31±0.13 |
| 治疗后 | 36 | 18.8±0.85 | 18.49±2.48 | 44.25±6.98 | 1.51±0.23 | 1.36±0.18 |
| t值 | 5.92 | 4.846 | 7.644 | 8.379 | 1.479 | |
| P值 | <0.05 | <0.05 | <0.05 | <0.05 | >0.05 |
| 组别 | 例数 | PT(s) | TT(s) | APTT(s) | INR | Fib(g/L) |
|---|---|---|---|---|---|---|
| 治疗前 | 36 | 23.27±0.92 | 24.68±5.04 | 61.50±9.24 | 2.32±0.37 | 1.31±0.13 |
| 治疗后 | 36 | 18.8±0.85 | 18.49±2.48 | 44.25±6.98 | 1.51±0.23 | 1.36±0.18 |
| t值 | 5.92 | 4.846 | 7.644 | 8.379 | 1.479 | |
| P值 | <0.05 | <0.05 | <0.05 | <0.05 | >0.05 |
| 组别 | 例数 | TP(g/L) | Alb(g/L) | TBil(μmol/L) | ALT(U/L) |
|---|---|---|---|---|---|
| 治疗前 | 36 | 55.87±3.44 | 29.09±2.61 | 495.13±25.88 | 561.34±75.86 |
| 治疗后 | 36 | 57.63±4.25 | 31.07±2.53 | 216.63±29.78 | 76.48±10.85 |
| t值 | 1.592 | 2.194 | 8.15 | 6.177 | |
| P值 | >0.05 | <0.05 | <0.05 | <0.05 | |
| 组别 | 例数 | AST(U/L) | CHE(U/L) | BUN(mmol/L) | |
| 治疗前 | 36 | 456.61±135.30 | 3976.86±808.48 | 10.68±1.78 | |
| 治疗后 | 36 | 90.76±24.40 | 5 843.52±774.64 | 8.18±1.95 | |
| t值 | 11.83 | 10.38 | 4.60 | ||
| P值 | <0.05 | <0.05 | <0.05 | ||
| 组别 | 例数 | TP(g/L) | Alb(g/L) | TBil(μmol/L) | ALT(U/L) |
|---|---|---|---|---|---|
| 治疗前 | 36 | 55.87±3.44 | 29.09±2.61 | 495.13±25.88 | 561.34±75.86 |
| 治疗后 | 36 | 57.63±4.25 | 31.07±2.53 | 216.63±29.78 | 76.48±10.85 |
| t值 | 1.592 | 2.194 | 8.15 | 6.177 | |
| P值 | >0.05 | <0.05 | <0.05 | <0.05 | |
| 组别 | 例数 | AST(U/L) | CHE(U/L) | BUN(mmol/L) | |
| 治疗前 | 36 | 456.61±135.30 | 3976.86±808.48 | 10.68±1.78 | |
| 治疗后 | 36 | 90.76±24.40 | 5 843.52±774.64 | 8.18±1.95 | |
| t值 | 11.83 | 10.38 | 4.60 | ||
| P值 | <0.05 | <0.05 | <0.05 | ||
| [1] | 中华医学会传染病与寄生虫病学分会主任委员. 病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. |
| [2] | 中华医学会感染病学分会肝衰竭与人工肝学组. 非生物型人工肝支持系统治疗肝衰竭指南(2009年版)[J]. 中华临床感染病杂志,2009,2(6):321-325. |
| [3] | 周建英,刘涛,刘海东.血浆置换对重型病毒性肝炎患者凝血功能指标的影响[J].透析与人工器官,2008,19(1):20-22. |
| [4] | 邱洁,冯艳红,张永臣,等.肝衰竭患者人工肝血浆置换前后凝血功能指标变化观察[J].安徽医药,2009,13(7):758-759. |
| [5] | 李兰娟,黄建荣,陈月美,等.人工肝支持系统治疗重症肝炎临床应用研究[J].中华传染病杂志,1999,17(4):11-13. |
| [6] | HAMAGUCHI M.Artificial liver support system:removal of bilirubin and bile acids by hemoperfusion with ionex-column[J].Nihon Geka Gakkai Zasshi,1983,84(1):63-73. |
| [7] | YOSHIBA M,LNOUE K,SEKIYAMA K,et al.Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure[J].Artif Organs,1996,20(11):1169-1172. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
